Display Settings:

Format

Send to:

Choose Destination

    Br J Ophthalmol. 1997 Feb;81(2):130-2.

    Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide.

    Rosenbaum JT, Simpson J, Neuwelt CM.

    Oregon Health Sciences University, Casey Eye Institute, Portland 97201, USA.

    BACKGROUND: Optic neuropathy is a rare manifestation of systemic lupus erythematosus (SLE). In a previous series most patients with optic neuropathy in association with SLE had a final visual acuity of 20/200 or less despite corticosteroid therapy. METHODS: Three patients (five affected eyes) with severe retrobulbar optic neuropathy in association with SLE were treated promptly with intravenous cyclophosphamide and corticosteroids. RESULTS: All patients recovered excellent visual acuity. CONCLUSION: Although optic neuropathy in association with SLE might have several different aetiologies, intravenous cyclophosphamide should be strongly considered as a therapeutic alternative.

    PMID: 9059246 [PubMed - indexed for MEDLINE]

    PMCID: 1722112

    Supplemental Content

    Click here to read Click here to read

    Patient drug information

    • Cyclophosphamide (Cytoxan®, Neosar®)

      Your doctor has ordered the drug cyclophosphamide to help treat your illness. The drug can be taken by mouth in tablet form or be given by injection into a vein.